Proglumide

Application Key intermediate for the synthesis of prostaglandins.

Application Key intermediate for the synthesis of prostaglandins.

11-deoxy-16,16-dimethyl Prostaglandin E2 is a stable synthetic analog of PGE2 , that has been shown to act as a selective agonist for both EP2 and EP3 receptors, unlike PGE2 which agonizes a variety of prostanoid receptors. This compound has shown

11-deoxy-16,16-dimethyl Prostaglandin E2 is a stable synthetic analog of PGE2 , that has been shown to act as a selective agonist for both EP2 and EP3 receptors, unlike PGE2 which agonizes a variety of prostanoid receptors. This compound has shown

11-deoxy-16,16-dimethyl PGE2 is a stable synthetic analog of PGE2. It is an agonist for both EP2 and EP3 receptors.

11-deoxy-16,16-dimethyl PGE2 is a stable synthetic analog of PGE2. It is an agonist for both EP2 and EP3 receptors.

11-deoxy-16,16-dimethyl PGE2 is a stable synthetic analog of PGE2. It is an agonist for both EP2 and EP3 receptors.

11&beta-PGE2 is the C-11 epimer of PGE2. It is a moderate inhibitor of PGE2 binding to rat hypothalamic membranes with a Ki value of 53 nM.

11&beta-PGE2 is the C-11 epimer of PGE2. It is a moderate inhibitor of PGE2 binding to rat hypothalamic membranes with a Ki value of 53 nM.

Misoprostol is a widely sold analog of prostaglandin E1 (PGE1) which has potent but relatively non-selective agonist activity with respect to the prostanoid EP receptor subgroup.(1) Misoprostol has been used therapeutically for many years in humans

Misoprostol is a widely sold analog of prostaglandin E1 (PGE1) which has potent but relatively non-selective agonist activity with respect to the prostanoid EP receptor subgroup.(1) Misoprostol has been used therapeutically for many years in humans

13,14-dihydro-15-keto Prostaglandin D|2|is a metabolite of PGD|2|which is formed through the 15-hydroxy PGDH pathway. It has been recently identified as a selective agonist for the DP|2|receptor. Additionally, 13,14-dihydro-15-keto Prostaglandin